TABLE 2.
Strain | ESBL | MLST | PG | Plasmid replicon type |
MIC |
bla gene product | Transfer | |||||
ATM | FEP | CTX | CAZ | CZO | FOX | |||||||
EC-2 | + | ST51 | B2 | FIA,FIB,FrepB | >16 | >16 | >32 | 16 | >16 | ≤ | OXA-30 | + |
EC-4 | + | ST9 | A | ND | 16 | 16 | >32 | ≤1 | >16 | 16 | OXA-30,CTX-M-65 | + |
EC-6 | + | ST45 | D | FIA,FIB,FrepB,N,K | ≤2 | >16 | 16 | ≤1 | >16 | ≤8 | CTX-M-14 | + |
EC-7 | + | ST48 | B2 | FIA,FIB,I1,K | >16 | >16 | >32 | 8 | >16 | ≤8 | TEM-1,CTX-M-55,CTX-M-14 | + |
EC-9 | + | ST95 | B2 | FIC,K | 8 | >16 | >32 | >16 | >16 | >32 | CMY-2,CTX-M-14 | + |
EC-13 | + | ST2 | B2 | FIA,FIB,FrepB,N,K | >16 | >16 | >32 | >16 | >16 | ≤8 | TEM-1 | + |
EC-20 | + | ST730 | B2 | FrepB,K | 4 | >16 | >32 | ≤1 | >16 | ≤8 | CTX-M-14 | + |
EC-24 | + | ST131 | B2 | FIB,FrepB,K | 8 | >16 | >32 | 4 | >16 | 16 | CTX-M-27 | + |
EC-25 | + | ST48 | B1 | FIB,FrepB,K | >16 | >16 | >32 | >16 | >16 | ≤8 | TEM-1 | + |
EC-27 | + | ST131 | B2 | FIA,FIB,FrepB,N,K | >16 | >16 | >32 | >16 | >16 | ≤8 | TEM-1,CTX-M-55 | + |
EC-29 | + | ST31 | B2 | FIA,FIB,FrepB,N,K | ≤2 | 16 | >32 | ≤1 | >16 | 16 | TEM-1 | + |
EC-31 | + | ST9 | D | FIB,FrepB,K | ≤2 | 16 | >32 | ≤1 | >16 | ≤8 | OXA-30,CTX-M-14 | + |
EC-32 | + | ST51 | D | I1,Y,K | >16 | >16 | >32 | 16 | >16 | ≤8 | TEM-1 | + |
EC-36 | + | ST131 | B2 | FIA,FIB,FrepB,N,K | >16 | >16 | >32 | >16 | >16 | ≤8 | CTX-M-27 | + |
EC-37 | + | ST2 | B2 | FIB,FrepB,K,P | 4 | >16 | >32 | ≤1 | >16 | ≤8 | TEM-1 | + |
EC-38 | + | ST95 | A | FIC | 8 | >16 | >32 | 2 | >16 | >32 | ADC-162 | + |
EC-39 | + | ST681 | B2 | FIA,FIB,FrepB | >16 | >16 | >32 | 2 | >16 | ≤8 | TEM-1,CTX-M-14 | + |
EC-41 | + | ST131 | B2 | FIB,FrepB,K | 16 | >16 | >32 | 4 | >16 | 16 | TEM-1,CTX-M-27 | + |
EC-43 | + | ST48 | D | K,B | 8 | >>16 | >32 | 2 | >16 | 16 | TEM-1,CTX-M-14 | + |
EC-48 | + | ST9 | B2 | FIA,FIB | >16 | >16 | >32 | >16 | >16 | 16 | TEM-1 | + |
EC-50 | + | ST9 | D | FIB,FrepB,K | ≤2 | >16 | >32 | ≤1 | >16 | 16 | OXA-30,CTX-M-14 | + |
PG, phylogenetic group; MIC, minimum inhibitory concentration.